↓ Skip to main content

Efficacy and safety of a 4-year combination therapy of growth hormone and gonadotropin-releasing hormone analogue in pubertal girls with short predicted adult height

Overview of attention for article published in Frontiers in endocrinology, March 2023
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
3 Dimensions

Readers on

mendeley
10 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Efficacy and safety of a 4-year combination therapy of growth hormone and gonadotropin-releasing hormone analogue in pubertal girls with short predicted adult height
Published in
Frontiers in endocrinology, March 2023
DOI 10.3389/fendo.2023.1113750
Pubmed ID
Authors

Hilde Dotremont, Annick France, Claudine Heinrichs, Sylvie Tenoutasse, Cécile Brachet, Martine Cools, Kathleen De Waele, Guy Massa, Marie-Christine Lebrethon, Inge Gies, Jesse Van Besien, Christine Derycke, Mathieu Ziraldo, Jean De Schepper, Véronique Beauloye, Stijn Verhulst, Raoul Rooman, Marieke den Brinker

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 10 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 10 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 2 20%
Student > Ph. D. Student 1 10%
Professor > Associate Professor 1 10%
Student > Bachelor 1 10%
Unknown 5 50%
Readers by discipline Count As %
Unspecified 2 20%
Medicine and Dentistry 2 20%
Economics, Econometrics and Finance 1 10%
Unknown 5 50%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 March 2023.
All research outputs
#23,368,516
of 26,038,372 outputs
Outputs from Frontiers in endocrinology
#8,547
of 13,341 outputs
Outputs of similar age
#379,777
of 441,623 outputs
Outputs of similar age from Frontiers in endocrinology
#503
of 852 outputs
Altmetric has tracked 26,038,372 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 13,341 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.2. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 441,623 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 852 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.